Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 275

1.

Emergence of Influenza A(H7N4) Virus, Cambodia.

Vijaykrishna D, Deng YM, Grau ML, Kay M, Suttie A, Horwood PF, Kalpravidh W, Claes F, Osbjer K, Dussart P, Barr IG, Karlsson EA.

Emerg Infect Dis. 2019 Oct 17;25(10). doi: 10.3201/eid2510.190506. [Epub ahead of print]

2.

Circulation and characterization of seasonal influenza viruses in Cambodia, 2012-2015.

Horwood PF, Karlsson EA, Horm SV, Ly S, Heng S, Chin S, Darapheak C, Saunders D, Chanthap L, Rith S, Y P, Chea KL, Sar B, Parry A, Ieng V, Tsuyouka R, Deng YM, Hurt AC, Barr IG, Komadina N, Buchy P, Dussart P.

Influenza Other Respir Viruses. 2019 Jun 28. doi: 10.1111/irv.12647. [Epub ahead of print]

3.

Respiratory Illness in a Piggery Associated with the First Identified Outbreak of Swine Influenza in Australia: Assessing the Risk to Human Health and Zoonotic Potential.

Smith DW, Barr IG, Loh R, Levy A, Tempone S, O'Dea M, Watson J, Wong FYK, Effler PV.

Trop Med Infect Dis. 2019 Jun 25;4(2). pii: E96. doi: 10.3390/tropicalmed4020096.

4.

Avian influenza in the Greater Mekong Subregion, 2003-2018.

Suttie A, Karlsson EA, Deng YM, Hurt AC, Greenhill AR, Barr IG, Dussart P, Horwood PF.

Infect Genet Evol. 2019 Jun 13;74:103920. doi: 10.1016/j.meegid.2019.103920. [Epub ahead of print] Review.

PMID:
31201870
5.

A Tale of Two Mutations: Beginning to Understand the Problems with Egg-Based Influenza Vaccines?

Subbarao K, Barr I.

Cell Host Microbe. 2019 Jun 12;25(6):773-775. doi: 10.1016/j.chom.2019.05.012.

PMID:
31194938
6.

Influenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading Frames.

Zanker DJ, Oveissi S, Tscharke DC, Duan M, Wan S, Zhang X, Xiao K, Mifsud NA, Gibbs J, Izzard L, Dlugolenski D, Faou P, Laurie KL, Vigneron N, Barr IG, Stambas J, Van den Eynde BJ, Bennink JR, Yewdell JW, Chen W.

J Immunol. 2019 Jun 15;202(12):3370-3380. doi: 10.4049/jimmunol.1900070. Epub 2019 May 15.

PMID:
31092636
7.

Patient-Provider Video Telemedicine Integrated With Clinical Care: Patient Experiences.

Reed ME, Huang J, Parikh R, Millman A, Ballard DW, Barr I, Wargon C.

Ann Intern Med. 2019 Apr 30. doi: 10.7326/M18-3081. [Epub ahead of print] No abstract available.

PMID:
31035294
8.

Human CD8+ T cell cross-reactivity across influenza A, B and C viruses.

Koutsakos M, Illing PT, Nguyen THO, Mifsud NA, Crawford JC, Rizzetto S, Eltahla AA, Clemens EB, Sant S, Chua BY, Wong CY, Allen EK, Teng D, Dash P, Boyd DF, Grzelak L, Zeng W, Hurt AC, Barr I, Rockman S, Jackson DC, Kotsimbos TC, Cheng AC, Richards M, Westall GP, Loudovaris T, Mannering SI, Elliott M, Tangye SG, Wakim LM, Rossjohn J, Vijaykrishna D, Luciani F, Thomas PG, Gras S, Purcell AW, Kedzierska K.

Nat Immunol. 2019 May;20(5):613-625. doi: 10.1038/s41590-019-0320-6. Epub 2019 Feb 18.

PMID:
30778243
9.

Rapid detection of new B/Victoria-lineage haemagglutinin variants of influenza B viruses by pyrosequencing.

Lau H, Deng YM, Xu X, Sessions W, Barr IG.

Diagn Microbiol Infect Dis. 2019 Apr;93(4):311-317. doi: 10.1016/j.diagmicrobio.2018.11.003. Epub 2018 Nov 13.

PMID:
30528425
10.

Cell culture-derived influenza vaccines in the severe 2017-2018 epidemic season: a step towards improved influenza vaccine effectiveness.

Barr IG, Donis RO, Katz JM, McCauley JW, Odagiri T, Trusheim H, Tsai TF, Wentworth DE.

NPJ Vaccines. 2018 Oct 9;3:44. doi: 10.1038/s41541-018-0079-z. eCollection 2018. Review.

11.

Real-Time Patient-Provider Video Telemedicine Integrated with Clinical Care.

Reed ME, Parikh R, Huang J, Ballard DW, Barr I, Wargon C.

N Engl J Med. 2018 Oct 11;379(15):1478-1479. doi: 10.1056/NEJMc1805746. No abstract available.

PMID:
30304654
12.

Semiannual Versus Annual Influenza Vaccination in Older Adults in the Tropics: An Observer-blind, Active-comparator-controlled, Randomized Superiority Trial.

Young B, Sadarangani S, Haur SY, Yung CF, Barr I, Connolly J, Chen M, Wilder-Smith A.

Clin Infect Dis. 2019 Jun 18;69(1):121-129. doi: 10.1093/cid/ciy836.

PMID:
30277500
13.

Influenza A(H5N1) viruses with A(H9N2) single gene (matrix or PB1) reassortment isolated from Cambodian live bird markets.

Suttie A, Karlsson EA, Deng YM, Horm SV, Yann S, Tok S, Sorn S, Holl D, Tum S, Hurt AC, Greenhill AR, Barr IG, Horwood PF, Dussart P.

Virology. 2018 Oct;523:22-26. doi: 10.1016/j.virol.2018.07.028. Epub 2018 Jul 31.

PMID:
30075357
14.

Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.

Korenkov DA, Laurie KL, Reading PC, Carolan LA, Chan KF, Isakova-Sivak II, Smolonogina TA, Subbarao K, Barr IG, Villanueva J, Shcherbik S, Bousse T, Rudenko LG.

Infect Genet Evol. 2018 Oct;64:95-104. doi: 10.1016/j.meegid.2018.06.019. Epub 2018 Jun 19.

PMID:
29929009
15.

Divergent Human-Origin Influenza Viruses Detected in Australian Swine Populations.

Wong FYK, Donato C, Deng YM, Teng D, Komadina N, Baas C, Modak J, O'Dea M, Smith DW, Effler PV, Cooke J, Davies KR, Hurt A, Kung N, Levy A, Loh R, Shan S, Shinwari MW, Stevens V, Taylor J, Williams DT, Watson J, Eagles D, McCullough S, Barr IG, Dhanasekaran V.

J Virol. 2018 Jul 31;92(16). pii: e00316-18. doi: 10.1128/JVI.00316-18. Print 2018 Aug 15.

16.

Annual report of the National Influenza Surveillance Scheme, 2010.

Gavin K, Owen R, Barr IG.

Commun Dis Intell Q Rep. 2017 Dec 1;41(4):E348-E368.

17.

Incidence of influenza A(H3N2) virus infections in Hong Kong in a longitudinal sero-epidemiological study, 2009-2015.

Wei VWI, Wong JYT, Perera RAPM, Kwok KO, Fang VJ, Barr IG, Peiris JSM, Riley S, Cowling BJ.

PLoS One. 2018 May 24;13(5):e0197504. doi: 10.1371/journal.pone.0197504. eCollection 2018.

18.

Ferrets as Models for Influenza Virus Transmission Studies and Pandemic Risk Assessments.

Belser JA, Barclay W, Barr I, Fouchier RAM, Matsuyama R, Nishiura H, Peiris M, Russell CJ, Subbarao K, Zhu H, Yen HL.

Emerg Infect Dis. 2018 Jun;24(6):965-971. doi: 10.3201/eid2406.172114.

19.

Detection of Low Pathogenicity Influenza A(H7N3) Virus during Duck Mortality Event, Cambodia, 2017.

Suttie A, Yann S, Y P, Tum S, Deng YM, Hul V, Horm VS, Barr I, Greenhill A, Horwood PF, Osbjer K, Karlsson EA, Dussart P.

Emerg Infect Dis. 2018 Jun;24(6):1103-1107. doi: 10.3201/eid2406.172099.

20.

Investigating Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret Model of Infection.

Chan KF, Carolan LA, Korenkov D, Druce J, McCaw J, Reading PC, Barr IG, Laurie KL.

J Infect Dis. 2018 Jul 2;218(3):406-417. doi: 10.1093/infdis/jiy184.

PMID:
29746640
21.

Difficulties of predicting the timing, size and severity of influenza seasons.

Barr IG, Cheng AC.

Respirology. 2018 Jun;23(6):562-563. doi: 10.1111/resp.13310. Epub 2018 Apr 11. Review. No abstract available.

22.

Correction: Continental synchronicity of human influenza virus epidemics despite climactic variation.

Geoghegan JL, Saavedra AF, Duchêne S, Sullivan S, Barr I, Holmes EC.

PLoS Pathog. 2018 Feb 7;14(2):e1006903. doi: 10.1371/journal.ppat.1006903. eCollection 2018 Feb.

23.

X-ray and EPR Characterization of the Auxiliary Fe-S Clusters in the Radical SAM Enzyme PqqE.

Barr I, Stich TA, Gizzi AS, Grove TL, Bonanno JB, Latham JA, Chung T, Wilmot CM, Britt RD, Almo SC, Klinman JP.

Biochemistry. 2018 Feb 27;57(8):1306-1315. doi: 10.1021/acs.biochem.7b01097. Epub 2018 Feb 6.

24.

The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia.

de Boer PT, Kelso JK, Halder N, Nguyen TP, Moyes J, Cohen C, Barr IG, Postma MJ, Milne GJ.

Vaccine. 2018 Feb 8;36(7):997-1007. doi: 10.1016/j.vaccine.2017.12.073. Epub 2018 Jan 17.

25.

Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.

Laurie KL, Horman W, Carolan LA, Chan KF, Layton D, Bean A, Vijaykrishna D, Reading PC, McCaw JM, Barr IG.

J Infect Dis. 2018 Jan 30;217(4):548-559. doi: 10.1093/infdis/jix509.

26.

Continental synchronicity of human influenza virus epidemics despite climatic variation.

Geoghegan JL, Saavedra AF, Duchêne S, Sullivan S, Barr I, Holmes EC.

PLoS Pathog. 2018 Jan 11;14(1):e1006780. doi: 10.1371/journal.ppat.1006780. eCollection 2018 Jan. Erratum in: PLoS Pathog. 2018 Feb 7;14 (2):e1006903.

27.

Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection.

Chan KF, Carolan LA, Druce J, Chappell K, Watterson D, Young P, Korenkov D, Subbarao K, Barr IG, Laurie KL, Reading PC.

J Virol. 2018 Jan 30;92(4). pii: e01322-17. doi: 10.1128/JVI.01322-17. Print 2018 Feb 15.

28.

Detection of adamantane-sensitive influenza A(H3N2) viruses in Australia, 2017: a cause for hope?

Hurt A, Komadina N, Deng YM, Kaye M, Sullivan S, Subbarao K, Barr I.

Euro Surveill. 2017 Nov;22(47). doi: 10.2807/1560-7917.ES.2017.22.47.17-00731.

29.

The first external quality assessment of isolation and identification of influenza viruses in cell culture in the Asia Pacific region, 2016.

Reading PC, Leung VK, Buettner I, Gillespie L, Deng YM, Shaw R, Spirason N, Todd A, Shah AS, Konings F, Barr IG.

J Clin Virol. 2017 Dec;97:54-58. doi: 10.1016/j.jcv.2017.10.018. Epub 2017 Nov 2.

PMID:
29127947
30.

Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region.

Jennings L, Huang QS, Barr I, Lee PI, Kim WJ, Buchy P, Sanicas M, Mungall BA, Chen J.

Influenza Other Respir Viruses. 2018 May;12(3):383-411. doi: 10.1111/irv.12522. Epub 2018 Mar 7. Review.

31.

Immune Responses to Twice-Annual Influenza Vaccination in Older Adults in Hong Kong.

Tam YH, Valkenburg SA, Perera RAPM, Wong JHF, Fang VJ, Ng TWY, Kwong ASK, Tsui WWS, Ip DKM, Poon LLM, Chau CKV, Barr IG, Peiris JSM, Cowling BJ.

Clin Infect Dis. 2018 Mar 5;66(6):904-912. doi: 10.1093/cid/cix900.

PMID:
29069368
32.

Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults.

Ana-Sosa-Batiz F, Johnston APR, Hogarth PM, Wines BD, Barr I, Wheatley AK, Kent SJ.

Vaccine. 2017 Nov 7;35(47):6451-6458. doi: 10.1016/j.vaccine.2017.09.062. Epub 2017 Oct 10.

PMID:
29029940
33.

Epidemiology and Relative Severity of Influenza Subtypes in Singapore in the Post-Pandemic Period from 2009 to 2010.

Goh EH, Jiang L, Hsu JP, Tan LWL, Lim WY, Phoon MC, Leo YS, Barr IG, Chow VTK, Lee VJ, Lin C, Lin R, Sadarangani SP, Young B, Chen MI.

Clin Infect Dis. 2017 Nov 13;65(11):1905-1913. doi: 10.1093/cid/cix694.

34.

Multiplex Reverse Transcription-PCR for Simultaneous Surveillance of Influenza A and B Viruses.

Zhou B, Deng YM, Barnes JR, Sessions OM, Chou TW, Wilson M, Stark TJ, Volk M, Spirason N, Halpin RA, Kamaraj US, Ding T, Stockwell TB, Salvatore M, Ghedin E, Barr IG, Wentworth DE.

J Clin Microbiol. 2017 Dec;55(12):3492-3501. doi: 10.1128/JCM.00957-17. Epub 2017 Oct 4.

35.

At the confluence of ribosomally synthesized peptide modification and radical S-adenosylmethionine (SAM) enzymology.

Latham JA, Barr I, Klinman JP.

J Biol Chem. 2017 Oct 6;292(40):16397-16405. doi: 10.1074/jbc.R117.797399. Epub 2017 Aug 22. Review.

36.

Rapid evolution of the PB1-F2 virulence protein expressed by human seasonal H3N2 influenza viruses reduces inflammatory responses to infection.

McAuley J, Deng YM, Gilbertson B, Mackenzie-Kludas C, Barr I, Brown L.

Virol J. 2017 Aug 22;14(1):162. doi: 10.1186/s12985-017-0827-0.

37.

Ibrutinib may impair serological responses to influenza vaccination.

Douglas AP, Trubiano JA, Barr I, Leung V, Slavin MA, Tam CS.

Haematologica. 2017 Oct;102(10):e397-e399. doi: 10.3324/haematol.2017.164285. Epub 2017 Jun 28. No abstract available.

38.

Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1.

Kwok KO, Riley S, Perera RAPM, Wei VWI, Wu P, Wei L, Chu DKW, Barr IG, Malik Peiris JS, Cowling BJ.

BMC Infect Dis. 2017 May 11;17(1):337. doi: 10.1186/s12879-017-2432-7.

39.

Assessing the potential pandemic risk of recent avian influenza viruses.

Barr IG.

Eur Respir J. 2017 Mar 8;49(3). pii: 1602517. doi: 10.1183/13993003.02517-2016. Print 2017 Mar. No abstract available.

40.

Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015.

Hampson A, Barr I, Cox N, Donis RO, Siddhivinayak H, Jernigan D, Katz J, McCauley J, Motta F, Odagiri T, Tam JS, Waddell A, Webby R, Ziegler T, Zhang W.

Vaccine. 2017 Feb 22;35(8):1104-1109. doi: 10.1016/j.vaccine.2017.01.018. Epub 2017 Jan 25. Review.

41.

CO and NO bind to Fe(II) DiGeorge critical region 8 heme but do not restore primary microRNA processing activity.

Hines JP, Smith AT, Jacob JP, Lukat-Rodgers GS, Barr I, Rodgers KR, Guo F, Burstyn JN.

J Biol Inorg Chem. 2016 Dec;21(8):1021-1035. Epub 2016 Oct 20.

42.

Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial.

Mcbride WJH, Abhayaratna WP, Barr I, Booy R, Carapetis J, Carson S, De Looze F, Ellis-Pegler R, Heron L, Karrasch J, Marshall H, Mcvernon J, Nolan T, Rawlinson W, Reid J, Richmond P, Shakib S, Basser RL, Hartel GF, Lai MH, Rockman S, Greenberg ME.

Vaccine. 2016 Sep 22;34(41):4991-4997. doi: 10.1016/j.vaccine.2016.08.038. Epub 2016 Aug 29.

43.

Evidence for the Introduction, Reassortment, and Persistence of Diverse Influenza A Viruses in Antarctica.

Hurt AC, Su YCF, Aban M, Peck H, Lau H, Baas C, Deng YM, Spirason N, Ellström P, Hernandez J, Olsen B, Barr IG, Vijaykrishna D, Gonzalez-Acuna D.

J Virol. 2016 Oct 14;90(21):9674-9682. doi: 10.1128/JVI.01404-16. Print 2016 Nov 1.

44.

What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.

Vanderven HA, Ana-Sosa-Batiz F, Jegaskanda S, Rockman S, Laurie K, Barr I, Chen W, Wines B, Hogarth PM, Lambe T, Gilbert SC, Parsons MS, Kent SJ.

EBioMedicine. 2016 Jun;8:277-290. doi: 10.1016/j.ebiom.2016.04.029. Epub 2016 Apr 28.

45.

Influenza C infections in Western Australia and Victoria from 2008 to 2014.

Jelley L, Levy A, Deng YM, Spirason N, Lang J, Buettner I, Druce J, Blyth C, Effler P, Smith D, Barr IG.

Influenza Other Respir Viruses. 2016 Nov;10(6):455-461. doi: 10.1111/irv.12402. Epub 2016 Jul 23.

46.

Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant.

Gordon DL, Sajkov D, Honda-Okubo Y, Wilks SH, Aban M, Barr IG, Petrovsky N.

Vaccine. 2016 Jul 19;34(33):3780-6. doi: 10.1016/j.vaccine.2016.05.071. Epub 2016 Jun 21.

47.

Influenza-Specific Antibody-Dependent Phagocytosis.

Ana-Sosa-Batiz F, Vanderven H, Jegaskanda S, Johnston A, Rockman S, Laurie K, Barr I, Reading P, Lichtfuss M, Kent SJ.

PLoS One. 2016 Apr 28;11(4):e0154461. doi: 10.1371/journal.pone.0154461. eCollection 2016.

48.

Demonstration That the Radical S-Adenosylmethionine (SAM) Enzyme PqqE Catalyzes de Novo Carbon-Carbon Cross-linking within a Peptide Substrate PqqA in the Presence of the Peptide Chaperone PqqD.

Barr I, Latham JA, Iavarone AT, Chantarojsiri T, Hwang JD, Klinman JP.

J Biol Chem. 2016 Apr 22;291(17):8877-84. doi: 10.1074/jbc.C115.699918. Epub 2016 Mar 8.

49.

Differential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season.

Barr IG, Vijaykrishna D, Sullivan SG.

Euro Surveill. 2016;21(4). doi: 10.2807/1560-7917.ES.2016.21.4.30118.

50.

Supplemental Content

Support Center